Perturbation of energy metabolism by fatty-acid derivative AIC-47 and imatinib in BCR-ABL-harboring leukemic cells-Reference-Cited by-同舟云学术

Perturbation of energy metabolism by fatty-acid derivative AIC-47 and imatinib in BCR-ABL-harboring leukemic cells

Published:2016-02 Issue:1 Volume:371 Page:1-11
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Shinohara Haruka,Kumazaki Minami,Minami Yosuke,Ito Yuko,Sugito Nobuhiko,Kuranaga Yuki,Taniguchi Kohei,Yamada Nami,Otsuki Yoshinori,Naoe Tomoki,Akao Yukihiro

Funder

Ministry of Education, Science, Sports, and Culture of Japan

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference38 articles.

1. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia;Druker;N. Engl. J. Med,2006

2. Translation of the Philadelphia chromosome into therapy for CML;Druker;Blood,2008

3. Novel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571;Nimmanapalli;Oncogene,2002

4. Targeting cellular metabolism to improve cancer therapeutics;Zhao;Cell Death Dis,2013

5. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Deconvolution of Bone Marrow Adipose Tissue Interactions with Malignant Hematopoiesis: Potential for New Therapy Development;Current Osteoporosis Reports;2024-06-26

2. Pan-cancer multi-omics analysis of PTBP1 reveals it as an inflammatory, progressive and prognostic marker in glioma;Scientific Reports;2024-06-25

3. Alternative splicing and related RNA binding proteins in human health and disease;Signal Transduction and Targeted Therapy;2024-02-02

4. RAVER1 hinders lethal EMT and modulates miR/RISC activity by the control of alternative splicing;Nucleic Acids Research;2024-02-01

5. CPT1A-mediated fatty acid oxidation confers cancer cell resistance to immune-mediated cytolytic killing;Proceedings of the National Academy of Sciences;2023-09-18